Open tender · Moldova · Pharmaceutical products
În scopul atribuirii contractelor subsecvente (pentru anul 2027) ca urmare a acordului-cadru nr. ocds-b3wdp1-MD-1718784284951 din 22.08.2024 încheiat prin procedura de achiziție publică nr. ocds-b3wdp1-MD-1718784284951 din 22.07.2024 privind încheierea acordului - cadru “Achiziționarea medicamentelor necesare pentru realizarea Programului Național Hipertensiunea pulmonară pentru anul 2025-2027, repetat 1”
In EnglishFor the award of subsequent contracts (for the year 2027) following the framework agreement no. ocds-b3wdp1-MD-1718784284951 of 22.08.2024 concluded through the public procurement procedure no. ocds-b3wdp1-MD-1718784284951 of 22.07.2024 concerning the conclusion of the framework agreement 'Acquisition of medicines necessary for the implementation of the National Pulmonary Hypertension Program for the years 2025-2027'
Centrul Pentru Achizitii Publice Centralizate in Sanatate
Centrul Pentru Achizitii Publice Centralizate in Sanatate in Moldova is inviting bids for “For the award of subsequent contracts (for the year 2027) following the framework agreement no”. Bids close on 9 November 2026, 16:00 EET; the estimated value is MDL 8.14 million. askTender lists every requirement to qualify and checks whether your company meets them.
Key facts
- Estimated value
- MDL 8.14 million
- Published
- 07 Oct 2026
Before you bid, askTender
Everything else is in your askTender account
The requirements to qualify, the eligibility check and the bid documents for this tender are in your askTender account.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: MTender, Ministry of Finance of Moldova. · Sources & licences